105 related articles for article (PubMed ID: 25741561)
1. Relevance of pCR in breast cancer trials.
Sikov WM
Oncology (Williston Park); 2014 Oct; 28(10):884, 886. PubMed ID: 25741561
[No Abstract] [Full Text] [Related]
2. Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".
Fehm T; Sauerbrei W
Breast Cancer Res Treat; 2010 Jul; 122(1):219-20. PubMed ID: 20130980
[No Abstract] [Full Text] [Related]
3. HER2-positive breast cancer metastatic to intracranial meningioma: a case report.
McCormack M; Rosa CS; Murphy M; Fox SB
J Clin Pathol; 2013 Jul; 66(7):633-4. PubMed ID: 23436926
[No Abstract] [Full Text] [Related]
4. A solitary bone lesion in a patient with previous breast cancer and the importance of bone biopsy: a case report and a review of guidelines.
Schiavon G; Tait DM; Briggs TW; Smith IE
Clin Breast Cancer; 2013 Feb; 13(1):77-80. PubMed ID: 23199805
[No Abstract] [Full Text] [Related]
5. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
DeCensi A; Pruneri G; Guerrieri-Gonzaga A
J Clin Oncol; 2012 Apr; 30(12):1384-6. PubMed ID: 22393083
[No Abstract] [Full Text] [Related]
6. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF
J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
[TBL] [Abstract][Full Text] [Related]
8. [New studies on breast cancer to predict disease outcome and clinical use of these new tests].
Kallioniemi OP; Holli K; Visakorpi T; Koivula T; Helin H; Isola J
Duodecim; 1991; 107(11):907-16. PubMed ID: 1364737
[No Abstract] [Full Text] [Related]
9. A proposed anatomical explanation for perineural spread of breast adenocarcinoma to the brachial plexus.
Hébert-Blouin MN; Amrami KK; Loukas M; Spinner RJ
Clin Anat; 2011 Jan; 24(1):101-5. PubMed ID: 21154646
[No Abstract] [Full Text] [Related]
10. Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials.
Tuma RS
J Natl Cancer Inst; 2007 Mar; 99(5):348-9. PubMed ID: 17341725
[No Abstract] [Full Text] [Related]
11. Breast cancer: search for new targets and improvement of existing techniques.
Bharath R; Parikh PM
Indian J Cancer; 2010; 47(2):95-7. PubMed ID: 20448369
[No Abstract] [Full Text] [Related]
12. Novel prognostic markers for patients with triple-negative breast cancer.
Zhou L; Li K; Luo Y; Tian L; Wang M; Li C; Huang Q
Hum Pathol; 2013 Oct; 44(10):2180-7. PubMed ID: 23845466
[TBL] [Abstract][Full Text] [Related]
13. The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis.
Zavyalova MV; Perelmuter VM; Vtorushin SV; Denisov EV; Litvyakov NV; Slonimskaya EM; Cherdyntseva NV
Diagn Cytopathol; 2013 Mar; 41(3):279-82. PubMed ID: 22102485
[No Abstract] [Full Text] [Related]
14. [Locally advanced breast cancer (methods of treatment)].
Portnoĭ SM
Vopr Onkol; 2011; 57(5):553-8. PubMed ID: 22238923
[No Abstract] [Full Text] [Related]
15. Recent advances in the adjuvant therapy of breast cancer.
Di Leo A
Tumori; 2000; 86(5 Suppl 1):S11-3. PubMed ID: 11195286
[No Abstract] [Full Text] [Related]
16. Neoadjuvant therapy: what are the lessons so far?
von Minckwitz G
Hematol Oncol Clin North Am; 2013 Aug; 27(4):767-84, ix. PubMed ID: 23915744
[TBL] [Abstract][Full Text] [Related]
17. Biology of residual breast cancer after therapy: a kinetic interpretation.
Norton L
Prog Clin Biol Res; 1990; 354A():109-32. PubMed ID: 2247484
[No Abstract] [Full Text] [Related]
18. Low grade periductal stromal sarcoma with marked sclero-elastosis.
Caltabiano R; Magro G; Vecchio GM; Lanzafame S
Pathology; 2011 Aug; 43(5):509-10. PubMed ID: 21753720
[No Abstract] [Full Text] [Related]
19. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
Cefaro GA; Genovesi D; Trignani M; DI Nicola M
Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
[TBL] [Abstract][Full Text] [Related]
20. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
